 |
|
Federal Court revisits the issue of medical uses by Lynn Ing In AbbVie Biotechnology Ltd v Canada (Attorney General), 2014 FC 1251, the Federal Court allowed AbbVie's appeal from a refusal of the Commissioner of Patents to grant Canadian Patent Application No. 2,385,745. The issue was solely a question of law, namely the Commissioner's determination of "the statutory limits of patentable subject matter... — that is, the nature and extent of the prohibition against methods of medical treatment". The Court held that the claims are patentable. |
Smart & Biggar/Fetherstonhaugh chosen by Managing Intellectual Property as "Canadian Specialty IP Firm of the Year" Smart & Biggar/Fetherstonhaugh tops the Canadian rankings for the second year in a row in the LMG Life Sciences 2014 |
|
Follow us on: The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly. |
|
||
|
|
||
|
|
|
